Description
Used in the treatment of:
- Severe osteoporosis in postmenopausal women and men at high risk of fractures
- Osteoporosis due to long-term glucocorticoid therapy
Teriparatide is a recombinant form of human parathyroid hormone (PTH 1–34) that stimulates osteoblast activity, increasing bone formation and strength.

![Teriparatide [rHu PTH (1-34)] Injection (r-DNA Origin)](https://biomedspecialitypharma.com/wp-content/uploads/2025/11/IMG-20250829-WA0058.jpg)
![Teriparatide [rHu PTH (1-34)] Injection (r-DNA Origin) - Image 2](https://biomedspecialitypharma.com/wp-content/uploads/2025/11/IMG-20250829-WA0057.jpg)
![Teriparatide [rHu PTH (1-34)] Injection (r-DNA Origin) - Image 3](https://biomedspecialitypharma.com/wp-content/uploads/2025/11/IMG-20250829-WA0056.jpg)